nodes	percent_of_prediction	percent_of_DWPC	metapath
Icosapent—TRPV1—nerve—acquired immunodeficiency syndrome	0.0216	0.0581	CbGeAlD
Icosapent—FFAR1—Peptide hormone metabolism—ENPEP—acquired immunodeficiency syndrome	0.0163	0.113	CbGpPWpGaD
Icosapent—ACSL3—digestive system—acquired immunodeficiency syndrome	0.0114	0.0305	CbGeAlD
Icosapent—Oropharyngeal pain—Abacavir—acquired immunodeficiency syndrome	0.01	0.0208	CcSEcCtD
Icosapent—FABP7—retina—acquired immunodeficiency syndrome	0.00988	0.0265	CbGeAlD
Icosapent—ACSL3—lung—acquired immunodeficiency syndrome	0.00951	0.0255	CbGeAlD
Icosapent—SLC8A1—digestive system—acquired immunodeficiency syndrome	0.00943	0.0253	CbGeAlD
Icosapent—Eructation—Stavudine—acquired immunodeficiency syndrome	0.0091	0.0188	CcSEcCtD
Icosapent—FADS1—retina—acquired immunodeficiency syndrome	0.00896	0.024	CbGeAlD
Icosapent—ACSL3—nervous system—acquired immunodeficiency syndrome	0.0088	0.0236	CbGeAlD
Icosapent—ACSL3—central nervous system—acquired immunodeficiency syndrome	0.00848	0.0227	CbGeAlD
Icosapent—ACSL4—retina—acquired immunodeficiency syndrome	0.00814	0.0218	CbGeAlD
Icosapent—Eructation—Zidovudine—acquired immunodeficiency syndrome	0.00791	0.0164	CcSEcCtD
Icosapent—Aspartate aminotransferase increased—Amprenavir—acquired immunodeficiency syndrome	0.00765	0.0158	CcSEcCtD
Icosapent—PPARG—endothelium—acquired immunodeficiency syndrome	0.00753	0.0202	CbGeAlD
Icosapent—Alanine aminotransferase increased—Amprenavir—acquired immunodeficiency syndrome	0.00749	0.0155	CcSEcCtD
Icosapent—Eructation—Indinavir—acquired immunodeficiency syndrome	0.00736	0.0152	CcSEcCtD
Icosapent—SLC8A1—nervous system—acquired immunodeficiency syndrome	0.00729	0.0196	CbGeAlD
Icosapent—SLC8A1—central nervous system—acquired immunodeficiency syndrome	0.00702	0.0188	CbGeAlD
Icosapent—FABP7—digestive system—acquired immunodeficiency syndrome	0.00694	0.0186	CbGeAlD
Icosapent—Oropharyngeal pain—Ritonavir—acquired immunodeficiency syndrome	0.00688	0.0142	CcSEcCtD
Icosapent—ACSL3—brain—acquired immunodeficiency syndrome	0.00673	0.0181	CbGeAlD
Icosapent—PPARG—blood plasma—acquired immunodeficiency syndrome	0.00669	0.0179	CbGeAlD
Icosapent—SLC8A1—Arrhythmogenic Right Ventricular Cardiomyopathy—ACTG1—acquired immunodeficiency syndrome	0.00667	0.0463	CbGpPWpGaD
Icosapent—Eructation—Delavirdine—acquired immunodeficiency syndrome	0.00665	0.0138	CcSEcCtD
Icosapent—FABP7—spinal cord—acquired immunodeficiency syndrome	0.00637	0.0171	CbGeAlD
Icosapent—Oropharyngeal pain—Lamivudine—acquired immunodeficiency syndrome	0.00632	0.0131	CcSEcCtD
Icosapent—TRPV1—digestive system—acquired immunodeficiency syndrome	0.00629	0.0169	CbGeAlD
Icosapent—Aspartate aminotransferase increased—Nevirapine—acquired immunodeficiency syndrome	0.00627	0.013	CcSEcCtD
Icosapent—Eructation—Ritonavir—acquired immunodeficiency syndrome	0.00615	0.0127	CcSEcCtD
Icosapent—Alanine aminotransferase increased—Nevirapine—acquired immunodeficiency syndrome	0.00614	0.0127	CcSEcCtD
Icosapent—Aspartate aminotransferase increased—Nelfinavir—acquired immunodeficiency syndrome	0.00607	0.0126	CcSEcCtD
Icosapent—FADS1—blood—acquired immunodeficiency syndrome	0.006	0.0161	CbGeAlD
Icosapent—Aspartate aminotransferase increased—Abacavir—acquired immunodeficiency syndrome	0.00596	0.0123	CcSEcCtD
Icosapent—Alanine aminotransferase increased—Nelfinavir—acquired immunodeficiency syndrome	0.00595	0.0123	CcSEcCtD
Icosapent—Eructation—Saquinavir—acquired immunodeficiency syndrome	0.00592	0.0123	CcSEcCtD
Icosapent—Alanine aminotransferase increased—Abacavir—acquired immunodeficiency syndrome	0.00584	0.0121	CcSEcCtD
Icosapent—FADS1—bone marrow—acquired immunodeficiency syndrome	0.0058	0.0156	CbGeAlD
Icosapent—FADS1—spinal cord—acquired immunodeficiency syndrome	0.00578	0.0155	CbGeAlD
Icosapent—TRPV1—spinal cord—acquired immunodeficiency syndrome	0.00578	0.0155	CbGeAlD
Icosapent—ACSL4—digestive system—acquired immunodeficiency syndrome	0.00571	0.0153	CbGeAlD
Icosapent—Eructation—Lamivudine—acquired immunodeficiency syndrome	0.00565	0.0117	CcSEcCtD
Icosapent—SLC8A1—brain—acquired immunodeficiency syndrome	0.00558	0.015	CbGeAlD
Icosapent—FADS1—vagina—acquired immunodeficiency syndrome	0.00556	0.0149	CbGeAlD
Icosapent—PPARD—lymphoid tissue—acquired immunodeficiency syndrome	0.00555	0.0149	CbGeAlD
Icosapent—PPARD—digestive system—acquired immunodeficiency syndrome	0.00549	0.0147	CbGeAlD
Icosapent—ACSL4—blood—acquired immunodeficiency syndrome	0.00544	0.0146	CbGeAlD
Icosapent—FABP7—nervous system—acquired immunodeficiency syndrome	0.00536	0.0144	CbGeAlD
Icosapent—ACSL4—bone marrow—acquired immunodeficiency syndrome	0.00527	0.0141	CbGeAlD
Icosapent—Aspartate aminotransferase increased—Zidovudine—acquired immunodeficiency syndrome	0.00526	0.0109	CcSEcCtD
Icosapent—FADS1—lung—acquired immunodeficiency syndrome	0.00526	0.0141	CbGeAlD
Icosapent—ACSL4—spinal cord—acquired immunodeficiency syndrome	0.00525	0.0141	CbGeAlD
Icosapent—FABP7—central nervous system—acquired immunodeficiency syndrome	0.00516	0.0139	CbGeAlD
Icosapent—Malnutrition—Amprenavir—acquired immunodeficiency syndrome	0.00512	0.0106	CcSEcCtD
Icosapent—ACSL4—vagina—acquired immunodeficiency syndrome	0.00505	0.0135	CbGeAlD
Icosapent—Aspartate aminotransferase increased—Indinavir—acquired immunodeficiency syndrome	0.00489	0.0101	CcSEcCtD
Icosapent—TRPV1—nervous system—acquired immunodeficiency syndrome	0.00487	0.0131	CbGeAlD
Icosapent—PPARD—vagina—acquired immunodeficiency syndrome	0.00485	0.013	CbGeAlD
Icosapent—Alanine aminotransferase increased—Indinavir—acquired immunodeficiency syndrome	0.00479	0.00992	CcSEcCtD
Icosapent—ACSL4—lung—acquired immunodeficiency syndrome	0.00477	0.0128	CbGeAlD
Icosapent—TRPV1—central nervous system—acquired immunodeficiency syndrome	0.00469	0.0126	CbGeAlD
Icosapent—PPARD—lung—acquired immunodeficiency syndrome	0.00458	0.0123	CbGeAlD
Icosapent—Aspartate aminotransferase increased—Delavirdine—acquired immunodeficiency syndrome	0.00442	0.00916	CcSEcCtD
Icosapent—ACSL4—nervous system—acquired immunodeficiency syndrome	0.00442	0.0119	CbGeAlD
Icosapent—FFAR1—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.00434	0.0301	CbGpPWpGaD
Icosapent—ACSL4—central nervous system—acquired immunodeficiency syndrome	0.00426	0.0114	CbGeAlD
Icosapent—PPARD—nervous system—acquired immunodeficiency syndrome	0.00424	0.0114	CbGeAlD
Icosapent—FABP7—brain—acquired immunodeficiency syndrome	0.0041	0.011	CbGeAlD
Icosapent—Aspartate aminotransferase increased—Ritonavir—acquired immunodeficiency syndrome	0.00409	0.00847	CcSEcCtD
Icosapent—PPARD—central nervous system—acquired immunodeficiency syndrome	0.00409	0.011	CbGeAlD
Icosapent—Malnutrition—Nelfinavir—acquired immunodeficiency syndrome	0.00406	0.00841	CcSEcCtD
Icosapent—Malnutrition—Stavudine—acquired immunodeficiency syndrome	0.00405	0.00838	CcSEcCtD
Icosapent—PTGS1—endothelium—acquired immunodeficiency syndrome	0.00402	0.0108	CbGeAlD
Icosapent—Malnutrition—Abacavir—acquired immunodeficiency syndrome	0.00399	0.00826	CcSEcCtD
Icosapent—Arthralgia—Didanosine—acquired immunodeficiency syndrome	0.00397	0.00822	CcSEcCtD
Icosapent—Dysgeusia—Stavudine—acquired immunodeficiency syndrome	0.00397	0.00821	CcSEcCtD
Icosapent—Aspartate aminotransferase increased—Saquinavir—acquired immunodeficiency syndrome	0.00394	0.00815	CcSEcCtD
Icosapent—Alanine aminotransferase increased—Saquinavir—acquired immunodeficiency syndrome	0.00386	0.00798	CcSEcCtD
Icosapent—PTGS2—endothelium—acquired immunodeficiency syndrome	0.00385	0.0103	CbGeAlD
Icosapent—Anaphylactic shock—Didanosine—acquired immunodeficiency syndrome	0.00381	0.00788	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Amprenavir—acquired immunodeficiency syndrome	0.0038	0.00788	CcSEcCtD
Icosapent—Aspartate aminotransferase increased—Lamivudine—acquired immunodeficiency syndrome	0.00376	0.00778	CcSEcCtD
Icosapent—FADS1—brain—acquired immunodeficiency syndrome	0.00372	0.00998	CbGeAlD
Icosapent—TRPV1—brain—acquired immunodeficiency syndrome	0.00372	0.00998	CbGeAlD
Icosapent—SLC8A1—Myometrial Relaxation and Contraction Pathways—ACTG1—acquired immunodeficiency syndrome	0.00369	0.0256	CbGpPWpGaD
Icosapent—Alanine aminotransferase increased—Lamivudine—acquired immunodeficiency syndrome	0.00368	0.00762	CcSEcCtD
Icosapent—Gastrointestinal disorder—Amprenavir—acquired immunodeficiency syndrome	0.0036	0.00746	CcSEcCtD
Icosapent—FADS1—lymph node—acquired immunodeficiency syndrome	0.00359	0.00964	CbGeAlD
Icosapent—PTGS1—blood plasma—acquired immunodeficiency syndrome	0.00357	0.00959	CbGeAlD
Icosapent—Arthralgia—Nevirapine—acquired immunodeficiency syndrome	0.00357	0.00739	CcSEcCtD
Icosapent—Malnutrition—Zidovudine—acquired immunodeficiency syndrome	0.00352	0.00729	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Didanosine—acquired immunodeficiency syndrome	0.00347	0.00718	CcSEcCtD
Icosapent—Arthralgia—Nelfinavir—acquired immunodeficiency syndrome	0.00346	0.00716	CcSEcCtD
Icosapent—Arthralgia—Stavudine—acquired immunodeficiency syndrome	0.00345	0.00714	CcSEcCtD
Icosapent—Dysgeusia—Zidovudine—acquired immunodeficiency syndrome	0.00345	0.00713	CcSEcCtD
Icosapent—Anaphylactic shock—Nevirapine—acquired immunodeficiency syndrome	0.00342	0.00709	CcSEcCtD
Icosapent—PTGS2—blood plasma—acquired immunodeficiency syndrome	0.00342	0.00917	CbGeAlD
Icosapent—Arthralgia—Abacavir—acquired immunodeficiency syndrome	0.0034	0.00703	CcSEcCtD
Icosapent—ACSL4—brain—acquired immunodeficiency syndrome	0.00338	0.00906	CbGeAlD
Icosapent—Dyspepsia—Didanosine—acquired immunodeficiency syndrome	0.00335	0.00694	CcSEcCtD
Icosapent—FFAR1—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.00331	0.0229	CbGpPWpGaD
Icosapent—Malnutrition—Indinavir—acquired immunodeficiency syndrome	0.00327	0.00678	CcSEcCtD
Icosapent—ACSL4—lymph node—acquired immunodeficiency syndrome	0.00326	0.00876	CbGeAlD
Icosapent—Anaphylactic shock—Abacavir—acquired immunodeficiency syndrome	0.00326	0.00674	CcSEcCtD
Icosapent—PPARD—brain—acquired immunodeficiency syndrome	0.00324	0.0087	CbGeAlD
Icosapent—PPARG—skin of body—acquired immunodeficiency syndrome	0.00321	0.00862	CbGeAlD
Icosapent—Dysgeusia—Indinavir—acquired immunodeficiency syndrome	0.00321	0.00664	CcSEcCtD
Icosapent—PPARD—lymph node—acquired immunodeficiency syndrome	0.00313	0.00841	CbGeAlD
Icosapent—Musculoskeletal discomfort—Nevirapine—acquired immunodeficiency syndrome	0.00312	0.00646	CcSEcCtD
Icosapent—Malnutrition—Efavirenz—acquired immunodeficiency syndrome	0.00309	0.0064	CcSEcCtD
Icosapent—FFAR1—Metabolism of proteins—ENPEP—acquired immunodeficiency syndrome	0.00307	0.0213	CbGpPWpGaD
Icosapent—Dysgeusia—Efavirenz—acquired immunodeficiency syndrome	0.00303	0.00627	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Nelfinavir—acquired immunodeficiency syndrome	0.00302	0.00625	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Stavudine—acquired immunodeficiency syndrome	0.00301	0.00623	CcSEcCtD
Icosapent—Arthralgia—Zidovudine—acquired immunodeficiency syndrome	0.003	0.0062	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Abacavir—acquired immunodeficiency syndrome	0.00297	0.00614	CcSEcCtD
Icosapent—Malnutrition—Delavirdine—acquired immunodeficiency syndrome	0.00296	0.00613	CcSEcCtD
Icosapent—Gastrointestinal disorder—Nevirapine—acquired immunodeficiency syndrome	0.00295	0.00612	CcSEcCtD
Icosapent—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.00295	0.00612	CcSEcCtD
Icosapent—Dyspepsia—Nelfinavir—acquired immunodeficiency syndrome	0.00292	0.00604	CcSEcCtD
Icosapent—Dyspepsia—Stavudine—acquired immunodeficiency syndrome	0.00291	0.00602	CcSEcCtD
Icosapent—Dysgeusia—Delavirdine—acquired immunodeficiency syndrome	0.0029	0.006	CcSEcCtD
Icosapent—Anaphylactic shock—Zidovudine—acquired immunodeficiency syndrome	0.00287	0.00595	CcSEcCtD
Icosapent—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	0.00286	0.00592	CcSEcCtD
Icosapent—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.00285	0.00591	CcSEcCtD
Icosapent—Constipation—Stavudine—acquired immunodeficiency syndrome	0.00283	0.00585	CcSEcCtD
Icosapent—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.00281	0.00582	CcSEcCtD
Icosapent—Arthralgia—Indinavir—acquired immunodeficiency syndrome	0.00279	0.00577	CcSEcCtD
Icosapent—Malnutrition—Ritonavir—acquired immunodeficiency syndrome	0.00274	0.00566	CcSEcCtD
Icosapent—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.00269	0.00558	CcSEcCtD
Icosapent—ACSL3—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.00269	0.0187	CbGpPWpGaD
Icosapent—Dysgeusia—Ritonavir—acquired immunodeficiency syndrome	0.00268	0.00555	CcSEcCtD
Icosapent—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.00267	0.00553	CcSEcCtD
Icosapent—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.00265	0.0055	CcSEcCtD
Icosapent—Malnutrition—Saquinavir—acquired immunodeficiency syndrome	0.00263	0.00545	CcSEcCtD
Icosapent—Arthralgia—Efavirenz—acquired immunodeficiency syndrome	0.00263	0.00545	CcSEcCtD
Icosapent—Rash—Amprenavir—acquired immunodeficiency syndrome	0.00263	0.00545	CcSEcCtD
Icosapent—FFAR1—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.00263	0.0182	CbGpPWpGaD
Icosapent—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.00263	0.00545	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	0.00262	0.00542	CcSEcCtD
Icosapent—PPARG—lymphoid tissue—acquired immunodeficiency syndrome	0.0026	0.00698	CbGeAlD
Icosapent—Dysgeusia—Saquinavir—acquired immunodeficiency syndrome	0.00258	0.00534	CcSEcCtD
Icosapent—PPARG—digestive system—acquired immunodeficiency syndrome	0.00257	0.0069	CbGeAlD
Icosapent—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.00253	0.00523	CcSEcCtD
Icosapent—Arthralgia—Delavirdine—acquired immunodeficiency syndrome	0.00252	0.00521	CcSEcCtD
Icosapent—Malnutrition—Lamivudine—acquired immunodeficiency syndrome	0.00251	0.0052	CcSEcCtD
Icosapent—PPARG—Circadian rythm related genes—CARTPT—acquired immunodeficiency syndrome	0.00251	0.0174	CbGpPWpGaD
Icosapent—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.00248	0.00513	CcSEcCtD
Icosapent—Dysgeusia—Lamivudine—acquired immunodeficiency syndrome	0.00246	0.00509	CcSEcCtD
Icosapent—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.00246	0.00508	CcSEcCtD
Icosapent—PPARG—blood—acquired immunodeficiency syndrome	0.00245	0.00657	CbGeAlD
Icosapent—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.00243	0.00504	CcSEcCtD
Icosapent—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.00242	0.00501	CcSEcCtD
Icosapent—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.00242	0.00501	CcSEcCtD
Icosapent—Rash—Didanosine—acquired immunodeficiency syndrome	0.0024	0.00497	CcSEcCtD
Icosapent—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.0024	0.00496	CcSEcCtD
Icosapent—FFAR1—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.00238	0.0165	CbGpPWpGaD
Icosapent—PPARG—bone marrow—acquired immunodeficiency syndrome	0.00237	0.00636	CbGeAlD
Icosapent—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.00235	0.00487	CcSEcCtD
Icosapent—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.00235	0.00486	CcSEcCtD
Icosapent—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.00234	0.00484	CcSEcCtD
Icosapent—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.00233	0.00482	CcSEcCtD
Icosapent—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.00231	0.00477	CcSEcCtD
Icosapent—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.0023	0.00477	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.0023	0.00476	CcSEcCtD
Icosapent—Constipation—Indinavir—acquired immunodeficiency syndrome	0.00228	0.00473	CcSEcCtD
Icosapent—PPARG—vagina—acquired immunodeficiency syndrome	0.00227	0.00609	CbGeAlD
Icosapent—FADS1—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.00226	0.0156	CbGpPWpGaD
Icosapent—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.00224	0.00464	CcSEcCtD
Icosapent—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.00222	0.0046	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.0022	0.00455	CcSEcCtD
Icosapent—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.00218	0.00451	CcSEcCtD
Icosapent—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.00218	0.00451	CcSEcCtD
Icosapent—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.00216	0.00447	CcSEcCtD
Icosapent—Rash—Nevirapine—acquired immunodeficiency syndrome	0.00216	0.00447	CcSEcCtD
Icosapent—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.00216	0.00446	CcSEcCtD
Icosapent—PPARG—lung—acquired immunodeficiency syndrome	0.00215	0.00576	CbGeAlD
Icosapent—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.00214	0.00443	CcSEcCtD
Icosapent—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.00213	0.0044	CcSEcCtD
Icosapent—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.00211	0.00436	CcSEcCtD
Icosapent—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.0021	0.00435	CcSEcCtD
Icosapent—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.00209	0.00433	CcSEcCtD
Icosapent—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.00209	0.00432	CcSEcCtD
Icosapent—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.00208	0.00432	CcSEcCtD
Icosapent—Rash—Stavudine—acquired immunodeficiency syndrome	0.00208	0.00431	CcSEcCtD
Icosapent—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.00208	0.00431	CcSEcCtD
Icosapent—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.00207	0.00429	CcSEcCtD
Icosapent—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.00207	0.00428	CcSEcCtD
Icosapent—Rash—Abacavir—acquired immunodeficiency syndrome	0.00205	0.00425	CcSEcCtD
Icosapent—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.00205	0.00425	CcSEcCtD
Icosapent—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.00205	0.00424	CcSEcCtD
Icosapent—ACSL4—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.00204	0.0141	CbGpPWpGaD
Icosapent—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.00203	0.00421	CcSEcCtD
Icosapent—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.00203	0.00421	CcSEcCtD
Icosapent—FFAR1—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.002	0.0139	CbGpPWpGaD
Icosapent—PPARG—nervous system—acquired immunodeficiency syndrome	0.00199	0.00533	CbGeAlD
Icosapent—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.00197	0.00407	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.00196	0.00405	CcSEcCtD
Icosapent—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.00193	0.00399	CcSEcCtD
Icosapent—PPARG—central nervous system—acquired immunodeficiency syndrome	0.00191	0.00514	CbGeAlD
Icosapent—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.00191	0.00395	CcSEcCtD
Icosapent—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.00189	0.00392	CcSEcCtD
Icosapent—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.00189	0.00391	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.00187	0.00387	CcSEcCtD
Icosapent—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.00186	0.00384	CcSEcCtD
Icosapent—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.00184	0.00381	CcSEcCtD
Icosapent—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.00183	0.00378	CcSEcCtD
Icosapent—FFAR1—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.00181	0.0126	CbGpPWpGaD
Icosapent—Rash—Zidovudine—acquired immunodeficiency syndrome	0.00181	0.00375	CcSEcCtD
Icosapent—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.00181	0.00375	CcSEcCtD
Icosapent—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.0018	0.00374	CcSEcCtD
Icosapent—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.00179	0.0037	CcSEcCtD
Icosapent—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.00177	0.00366	CcSEcCtD
Icosapent—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.00175	0.00363	CcSEcCtD
Icosapent—PTGS1—skin of body—acquired immunodeficiency syndrome	0.00172	0.00461	CbGeAlD
Icosapent—FFAR1—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.00172	0.0119	CbGpPWpGaD
Icosapent—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.00171	0.00354	CcSEcCtD
Icosapent—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.0017	0.00352	CcSEcCtD
Icosapent—FFAR1—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.0017	0.0118	CbGpPWpGaD
Icosapent—Rash—Indinavir—acquired immunodeficiency syndrome	0.00168	0.00349	CcSEcCtD
Icosapent—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.00168	0.00348	CcSEcCtD
Icosapent—PTGS2—skin of body—acquired immunodeficiency syndrome	0.00164	0.00441	CbGeAlD
Icosapent—PPARD—RXR and RAR heterodimerization with other nuclear receptor—TNF—acquired immunodeficiency syndrome	0.00164	0.0114	CbGpPWpGaD
Icosapent—FFAR1—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.00163	0.0113	CbGpPWpGaD
Icosapent—FFAR1—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.00161	0.0112	CbGpPWpGaD
Icosapent—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.0016	0.00332	CcSEcCtD
Icosapent—Rash—Efavirenz—acquired immunodeficiency syndrome	0.00159	0.00329	CcSEcCtD
Icosapent—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.00159	0.00329	CcSEcCtD
Icosapent—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.00158	0.00327	CcSEcCtD
Icosapent—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.00154	0.00318	CcSEcCtD
Icosapent—Rash—Delavirdine—acquired immunodeficiency syndrome	0.00152	0.00315	CcSEcCtD
Icosapent—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.00152	0.00315	CcSEcCtD
Icosapent—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.00152	0.00315	CcSEcCtD
Icosapent—PPARG—brain—acquired immunodeficiency syndrome	0.00152	0.00408	CbGeAlD
Icosapent—FFAR1—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.00147	0.0102	CbGpPWpGaD
Icosapent—PPARG—lymph node—acquired immunodeficiency syndrome	0.00147	0.00394	CbGeAlD
Icosapent—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.00145	0.003	CcSEcCtD
Icosapent—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.00142	0.00294	CcSEcCtD
Icosapent—ACSL3—Metabolism—TAT—acquired immunodeficiency syndrome	0.00141	0.00978	CbGpPWpGaD
Icosapent—Rash—Ritonavir—acquired immunodeficiency syndrome	0.00141	0.00291	CcSEcCtD
Icosapent—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.00141	0.00291	CcSEcCtD
Icosapent—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—acquired immunodeficiency syndrome	0.00139	0.00967	CbGpPWpGaD
Icosapent—FFAR1—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.00138	0.00958	CbGpPWpGaD
Icosapent—FFAR1—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.00138	0.00958	CbGpPWpGaD
Icosapent—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CSF2—acquired immunodeficiency syndrome	0.00138	0.00956	CbGpPWpGaD
Icosapent—PTGS1—digestive system—acquired immunodeficiency syndrome	0.00137	0.00369	CbGeAlD
Icosapent—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.00137	0.00283	CcSEcCtD
Icosapent—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—acquired immunodeficiency syndrome	0.00136	0.00941	CbGpPWpGaD
Icosapent—Rash—Saquinavir—acquired immunodeficiency syndrome	0.00136	0.00281	CcSEcCtD
Icosapent—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.00135	0.0028	CcSEcCtD
Icosapent—PTGS2—lymphoid tissue—acquired immunodeficiency syndrome	0.00133	0.00357	CbGeAlD
Icosapent—PTGS2—digestive system—acquired immunodeficiency syndrome	0.00131	0.00352	CbGeAlD
Icosapent—PTGS1—blood—acquired immunodeficiency syndrome	0.00131	0.00351	CbGeAlD
Icosapent—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.0013	0.0027	CcSEcCtD
Icosapent—Rash—Lamivudine—acquired immunodeficiency syndrome	0.00129	0.00268	CcSEcCtD
Icosapent—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.00129	0.00267	CcSEcCtD
Icosapent—PTGS1—spinal cord—acquired immunodeficiency syndrome	0.00126	0.00338	CbGeAlD
Icosapent—PTGS2—blood—acquired immunodeficiency syndrome	0.00125	0.00336	CbGeAlD
Icosapent—FFAR1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.00124	0.00858	CbGpPWpGaD
Icosapent—PTGS1—vagina—acquired immunodeficiency syndrome	0.00121	0.00326	CbGeAlD
Icosapent—PTGS2—bone marrow—acquired immunodeficiency syndrome	0.00121	0.00325	CbGeAlD
Icosapent—PTGS2—spinal cord—acquired immunodeficiency syndrome	0.00121	0.00323	CbGeAlD
Icosapent—ACSL3—Metabolism—AGPS—acquired immunodeficiency syndrome	0.0012	0.00831	CbGpPWpGaD
Icosapent—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—acquired immunodeficiency syndrome	0.0012	0.00831	CbGpPWpGaD
Icosapent—PTGS2—Calcium signaling in the CD4+ TCR pathway—CSF2—acquired immunodeficiency syndrome	0.00119	0.00822	CbGpPWpGaD
Icosapent—FADS1—Metabolism—TAT—acquired immunodeficiency syndrome	0.00118	0.00819	CbGpPWpGaD
Icosapent—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—acquired immunodeficiency syndrome	0.00117	0.00809	CbGpPWpGaD
Icosapent—PTGS2—vagina—acquired immunodeficiency syndrome	0.00116	0.00311	CbGeAlD
Icosapent—PTGS1—lung—acquired immunodeficiency syndrome	0.00115	0.00308	CbGeAlD
Icosapent—PPARD—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.00115	0.00795	CbGpPWpGaD
Icosapent—FFAR1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.00112	0.00776	CbGpPWpGaD
Icosapent—FFAR1—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.00111	0.00767	CbGpPWpGaD
Icosapent—PPARG—Regulation of retinoblastoma protein—CSF2—acquired immunodeficiency syndrome	0.0011	0.00766	CbGpPWpGaD
Icosapent—PTGS2—lung—acquired immunodeficiency syndrome	0.0011	0.00294	CbGeAlD
Icosapent—PPARD—Generic Transcription Pathway—CCNT1—acquired immunodeficiency syndrome	0.00109	0.00756	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—TAT—acquired immunodeficiency syndrome	0.00107	0.00741	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—TAT—acquired immunodeficiency syndrome	0.00107	0.00741	CbGpPWpGaD
Icosapent—PTGS1—nervous system—acquired immunodeficiency syndrome	0.00106	0.00285	CbGeAlD
Icosapent—FFAR1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.00105	0.0073	CbGpPWpGaD
Icosapent—FFAR1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.00105	0.0073	CbGpPWpGaD
Icosapent—FFAR1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.00105	0.00729	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00103	0.00713	CbGpPWpGaD
Icosapent—PTGS1—central nervous system—acquired immunodeficiency syndrome	0.00102	0.00275	CbGeAlD
Icosapent—PPARG—Transcription factor regulation in adipogenesis—TNF—acquired immunodeficiency syndrome	0.00102	0.0071	CbGpPWpGaD
Icosapent—PTGS2—nervous system—acquired immunodeficiency syndrome	0.00102	0.00273	CbGeAlD
Icosapent—FADS1—Metabolism—AGPS—acquired immunodeficiency syndrome	0.001	0.00697	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.001	0.00695	CbGpPWpGaD
Icosapent—PTGS2—central nervous system—acquired immunodeficiency syndrome	0.000978	0.00262	CbGeAlD
Icosapent—FFAR1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000947	0.00657	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.00093	0.00645	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000909	0.0063	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000909	0.0063	CbGpPWpGaD
Icosapent—PPARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—acquired immunodeficiency syndrome	0.000895	0.00621	CbGpPWpGaD
Icosapent—SLC8A1—Hemostasis—IFNA1—acquired immunodeficiency syndrome	0.000832	0.00577	CbGpPWpGaD
Icosapent—PPARG—Transcription factor regulation in adipogenesis—IL6—acquired immunodeficiency syndrome	0.000826	0.00573	CbGpPWpGaD
Icosapent—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—acquired immunodeficiency syndrome	0.00082	0.00569	CbGpPWpGaD
Icosapent—PTGS1—brain—acquired immunodeficiency syndrome	0.000812	0.00218	CbGeAlD
Icosapent—PTGS1—Overview of nanoparticle effects—TNF—acquired immunodeficiency syndrome	0.000806	0.00559	CbGpPWpGaD
Icosapent—FFAR1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000801	0.00555	CbGpPWpGaD
Icosapent—PTGS1—lymph node—acquired immunodeficiency syndrome	0.000785	0.00211	CbGeAlD
Icosapent—PTGS2—brain—acquired immunodeficiency syndrome	0.000777	0.00208	CbGeAlD
Icosapent—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—acquired immunodeficiency syndrome	0.000775	0.00538	CbGpPWpGaD
Icosapent—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CSF2—acquired immunodeficiency syndrome	0.000767	0.00532	CbGpPWpGaD
Icosapent—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—acquired immunodeficiency syndrome	0.000754	0.00523	CbGpPWpGaD
Icosapent—PTGS2—lymph node—acquired immunodeficiency syndrome	0.00075	0.00201	CbGeAlD
Icosapent—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—acquired immunodeficiency syndrome	0.000729	0.00505	CbGpPWpGaD
Icosapent—SLC8A1—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	0.000723	0.00501	CbGpPWpGaD
Icosapent—FFAR1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000721	0.005	CbGpPWpGaD
Icosapent—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—acquired immunodeficiency syndrome	0.000705	0.00489	CbGpPWpGaD
Icosapent—SLC8A1—Hemostasis—CSF2—acquired immunodeficiency syndrome	0.000651	0.00451	CbGpPWpGaD
Icosapent—PTGS1—Overview of nanoparticle effects—IL6—acquired immunodeficiency syndrome	0.000651	0.00451	CbGpPWpGaD
Icosapent—PTGS2—Overview of nanoparticle effects—TNF—acquired immunodeficiency syndrome	0.00064	0.00444	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000635	0.0044	CbGpPWpGaD
Icosapent—FFAR1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000633	0.00439	CbGpPWpGaD
Icosapent—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—acquired immunodeficiency syndrome	0.000626	0.00434	CbGpPWpGaD
Icosapent—PPARG—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.000626	0.00434	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000607	0.00421	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000607	0.00421	CbGpPWpGaD
Icosapent—PPARD—Metabolism—TAT—acquired immunodeficiency syndrome	0.000601	0.00416	CbGpPWpGaD
Icosapent—PPARG—Generic Transcription Pathway—CCNT1—acquired immunodeficiency syndrome	0.000595	0.00413	CbGpPWpGaD
Icosapent—FFAR1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000595	0.00412	CbGpPWpGaD
Icosapent—FFAR1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000595	0.00412	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000574	0.00398	CbGpPWpGaD
Icosapent—ACSL3—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	0.000552	0.00383	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000549	0.00381	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—CCR2—acquired immunodeficiency syndrome	0.000547	0.0038	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.00054	0.00375	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.00054	0.00375	CbGpPWpGaD
Icosapent—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—acquired immunodeficiency syndrome	0.000531	0.00368	CbGpPWpGaD
Icosapent—PPARD—Gene Expression—CCNT1—acquired immunodeficiency syndrome	0.000525	0.00364	CbGpPWpGaD
Icosapent—SLC8A1—Myometrial Relaxation and Contraction Pathways—IL6—acquired immunodeficiency syndrome	0.000521	0.00361	CbGpPWpGaD
Icosapent—PTGS2—Overview of nanoparticle effects—IL6—acquired immunodeficiency syndrome	0.000516	0.00358	CbGpPWpGaD
Icosapent—PPARD—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000511	0.00354	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—ACTG1—acquired immunodeficiency syndrome	0.000486	0.00337	CbGpPWpGaD
Icosapent—FADS1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	0.000463	0.00321	CbGpPWpGaD
Icosapent—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—acquired immunodeficiency syndrome	0.000456	0.00316	CbGpPWpGaD
Icosapent—PPARD—Adipogenesis—TNF—acquired immunodeficiency syndrome	0.000453	0.00314	CbGpPWpGaD
Icosapent—FFAR1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000452	0.00314	CbGpPWpGaD
Icosapent—FFAR1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000446	0.00309	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.000439	0.00304	CbGpPWpGaD
Icosapent—FFAR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.000434	0.00301	CbGpPWpGaD
Icosapent—SLC8A1—Hemostasis—ALB—acquired immunodeficiency syndrome	0.000424	0.00294	CbGpPWpGaD
Icosapent—ACSL4—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	0.000418	0.0029	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000411	0.00285	CbGpPWpGaD
Icosapent—FFAR1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000408	0.00283	CbGpPWpGaD
Icosapent—PPARG—Signaling events mediated by HDAC Class I—TNF—acquired immunodeficiency syndrome	0.000405	0.00281	CbGpPWpGaD
Icosapent—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—acquired immunodeficiency syndrome	0.000405	0.00281	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000405	0.00281	CbGpPWpGaD
Icosapent—PTGS1—Selenium Micronutrient Network—ALB—acquired immunodeficiency syndrome	0.0004	0.00278	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—IL4—acquired immunodeficiency syndrome	0.000379	0.00263	CbGpPWpGaD
Icosapent—PPARG—Transcriptional regulation of white adipocyte differentiation—TNF—acquired immunodeficiency syndrome	0.000376	0.0026	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000375	0.0026	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.00037	0.00257	CbGpPWpGaD
Icosapent—SLC8A1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	0.000367	0.00255	CbGpPWpGaD
Icosapent—PTGS1—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	0.000365	0.00253	CbGpPWpGaD
Icosapent—PPARD—Adipogenesis—IL6—acquired immunodeficiency syndrome	0.000365	0.00253	CbGpPWpGaD
Icosapent—TRPV1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	0.000355	0.00246	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.000348	0.00241	CbGpPWpGaD
Icosapent—SLC8A1—Hemostasis—IL2—acquired immunodeficiency syndrome	0.000344	0.00238	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000339	0.00235	CbGpPWpGaD
Icosapent—PPARG—Metabolism—TAT—acquired immunodeficiency syndrome	0.000328	0.00227	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000319	0.00221	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000319	0.00221	CbGpPWpGaD
Icosapent—PTGS2—Selenium Micronutrient Network—ALB—acquired immunodeficiency syndrome	0.000318	0.0022	CbGpPWpGaD
Icosapent—PTGS2—Aryl Hydrocarbon Receptor—TNF—acquired immunodeficiency syndrome	0.000315	0.00219	CbGpPWpGaD
Icosapent—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—acquired immunodeficiency syndrome	0.000295	0.00205	CbGpPWpGaD
Icosapent—PTGS2—C-MYB transcription factor network—CD4—acquired immunodeficiency syndrome	0.000291	0.00202	CbGpPWpGaD
Icosapent—PTGS2—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	0.00029	0.00201	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—CCNT1—acquired immunodeficiency syndrome	0.000287	0.00199	CbGpPWpGaD
Icosapent—PPARG—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000279	0.00193	CbGpPWpGaD
Icosapent—PPARG—Adipogenesis—TNF—acquired immunodeficiency syndrome	0.000247	0.00171	CbGpPWpGaD
Icosapent—ACSL3—Metabolism—ALB—acquired immunodeficiency syndrome	0.000246	0.0017	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000243	0.00168	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000239	0.00166	CbGpPWpGaD
Icosapent—PTGS1—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	0.000236	0.00164	CbGpPWpGaD
Icosapent—FFAR1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000236	0.00163	CbGpPWpGaD
Icosapent—PPARD—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	0.000235	0.00163	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—TAT—acquired immunodeficiency syndrome	0.00023	0.00159	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—IFNG—acquired immunodeficiency syndrome	0.000229	0.00159	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000219	0.00152	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000214	0.00148	CbGpPWpGaD
Icosapent—FADS1—Metabolism—ALB—acquired immunodeficiency syndrome	0.000206	0.00143	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—IL2—acquired immunodeficiency syndrome	0.000204	0.00141	CbGpPWpGaD
Icosapent—PPARG—Adipogenesis—IL6—acquired immunodeficiency syndrome	0.000199	0.00138	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000195	0.00135	CbGpPWpGaD
Icosapent—PTGS1—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	0.000191	0.00132	CbGpPWpGaD
Icosapent—PTGS2—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	0.000188	0.0013	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—ALB—acquired immunodeficiency syndrome	0.000186	0.00129	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—ALB—acquired immunodeficiency syndrome	0.000186	0.00129	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—TAT—acquired immunodeficiency syndrome	0.000182	0.00126	CbGpPWpGaD
Icosapent—PTGS2—Disease—APOBEC3G—acquired immunodeficiency syndrome	0.000174	0.00121	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000155	0.00108	CbGpPWpGaD
Icosapent—PTGS2—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	0.000152	0.00105	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—TNF—acquired immunodeficiency syndrome	0.000148	0.00103	CbGpPWpGaD
Icosapent—PTGS2—Disease—CCNT1—acquired immunodeficiency syndrome	0.000148	0.00103	CbGpPWpGaD
Icosapent—PPARG—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	0.000141	0.000976	CbGpPWpGaD
Icosapent—PPARG—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	0.000128	0.00089	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000126	0.000876	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000126	0.000872	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—IL6—acquired immunodeficiency syndrome	0.00012	0.000831	CbGpPWpGaD
Icosapent—PPARD—Metabolism—ALB—acquired immunodeficiency syndrome	0.000105	0.000726	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	0.000101	0.0007	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	8.99e-05	0.000624	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—TNF—acquired immunodeficiency syndrome	8.49e-05	0.000589	CbGpPWpGaD
Icosapent—PTGS2—Disease—CXCR4—acquired immunodeficiency syndrome	7.78e-05	0.000539	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	7.43e-05	0.000515	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	7.14e-05	0.000495	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—IL6—acquired immunodeficiency syndrome	6.85e-05	0.000475	CbGpPWpGaD
Icosapent—PPARG—Metabolism—ALB—acquired immunodeficiency syndrome	5.72e-05	0.000397	CbGpPWpGaD
Icosapent—PTGS2—Disease—CCR5—acquired immunodeficiency syndrome	5.33e-05	0.00037	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—ALB—acquired immunodeficiency syndrome	4.01e-05	0.000278	CbGpPWpGaD
Icosapent—PTGS2—Disease—CD4—acquired immunodeficiency syndrome	3.35e-05	0.000232	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—ALB—acquired immunodeficiency syndrome	3.18e-05	0.000221	CbGpPWpGaD
Icosapent—PTGS2—Disease—IL6—acquired immunodeficiency syndrome	1.81e-05	0.000126	CbGpPWpGaD
